viewInnoCan Pharma

Innocan Pharma strikes deal to distribute its SHIR line of CBD beauty products in Italy and Switzerland

The distribution agreement with Cloud 9 Switzerland LLC will see it sell Innocan’s SHIR Beauty and Relief & Go lines in the two countries

InnoCan Pharma -
The deal marks Innocan's second distribution agreement in Europe

Innocan Pharma Corporation (CSE:INNO) said Thursday that it inked a deal to distribute its CBD line of beauty and pharmaceutical products in Italy and Switzerland.

The distribution agreement with Cloud 9 Switzerland LLC will see it sell Innocan’s SHIR Beauty and Relief & Go lines in the two countries, according to a release.

Iris Bincovich, Innocan’s CEO, expressed the company’s excitement to see its products distributed in Italy and Switerland.

READ: Innocan Pharma subsidiary inks manufacturing and distribution deal with Calgary cannabis producer Endless Sky

“This is the second distribution agreement we have signed in Europe,” Bincovich said in a statement. “I believe Cloud 9 will provide professional distribution of our SHIR and Relief & Go product lines."

Cloud 9 and its subsidiaries are active in the health and wellness sectors by developing, producing and commercialising hemp- and cannabis-based pharmaceuticals and nutraceuticals.

"In these extraordinary times, cannabis-based pharma and cosmetic products respond to consumers' desires for a more natural and healthy lifestyle,” Cloud 9’s managing director Dr Francis Scanlan said in a statement.

“Innocan has a proven high-level expertise and shared vision making them an ideal partner for us to develop these new markets.”

Also in Thursday’s statement, Innocan said it has engaged AGORACOM for a 12-month online marketing campaign to broaden its pool of potential investors. In consideration, Innocan will pay $75,000 worth of shares payable in five equal installments during the period from August 2020 to July 2021.  

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: InnoCan Pharma


Price: 1 CAD

Market Cap: $221.45 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Phoenix Copper updates investors on Empire copper-oxide open pit

Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF, FRA:5HR) CEO Ryan McDermott joined Proactive's Stephen Gunnion with an update on the company's Empire copper-oxide open pit and 2021 drilling program. McDermott telling Proactive that the construction of a permanent office in Mackay is a significant...

14 hours, 28 minutes ago

2 min read